Biomedical
The novel fusogenic peptides improve the delivery of therapeutics for ovarian cancer through their ability to enhance endosomal escape and delivery of bioactive therapeutics. Epithelial ovarian cancer is the 5th leading cancer among women, with a 49% five-year survival rate. Current treatment strategies for ovarian cancer include surgical removal, chemotherapy, and radiation; however, these treatments often prove ineffective or toxic…
Inventor: Angela Alexander-Bryant, Timothy Samec
Published: 12/6/2022
Biotechnology, Biomedical
Clemson University researchers have developed an in vitro
myocardial therapy screening platform possessing superior
physiological relevance that enables clinically translatable metrics
for therapy efficacy and cardiotoxicity evaluation.
Inventor: William Richardson, Samuel Coeyman, Jonathan G. Heywood
Published: 2/14/2022
Biomedical
Clemson University researchers have created an at-home diagnostic platform for chronic kidney disease patients that provides an accurate and immediate measurement of the ammonia concentration in exhaled breath without any electronic components.
Inventor: Dr. Robert Latour
Dr. George Chumanov
Published: 12/17/2021
Biomedical
Clemson University and Emory University researchers have partnered up to uncover the efficacy that Ibrutinib can have in targeting and reversing the expression of cocaine addiction genes in human meso-cortico-limbic circuitry.
Inventor: Robert Anholt and
Trudy Mackay
Published: 10/26/2021
Biomedical
Clemson University researchers developed a new design that provides an alternative surgical treatment to arthrodesis.
Inventor: John DesJardins,
Eric Lucas,
Kim Chillag,
Frank Voss
Published: 8/12/2021
